| 451 |
Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies |
1993 |
| 452 |
Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis |
1993 |
| 453 |
Synthesis of chelating oxazole Derivatives with potential biological activity |
1993 |
| 454 |
Interaction between verapamil and vincristine binding to plasma proteins. |
1992 |
| 455 |
Antinociceptive activity of some tricyclic antidepressants. |
1991 |
| 456 |
Further investigation of the central effects of a calcium-entry blocker (Verapamil) |
1991 |
| 457 |
Interaction of butorphanol with monoamine oxidase inhibitor, tranylcypromine. |
1991 |
| 458 |
Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium phosphate |
1990 |
| 459 |
Effects of cyproheptadine on morphine-withdrawal signs |
1990 |
| 460 |
Mechanisms of metabolic changes induced by calcium entry blockers |
1990 |
هل لديك سؤال ؟
